Adaptive Biotechnologies President and COO Julie Rubinstein reports sale of $897,456.68 in common shares
ADPT•Julie Rubinstein sold 35,643 Adaptive Biotechnologies common shares from Oct. 22 through Oct. 26, 2026, and exercised options for the same number of shares at $12.14 each.
1. Share transaction
Rubinstein’s direct common stock holdings remained unchanged at 377,802 shares. She had 165,919 stock options remaining.
